GLP-1 Microdosing Age-Specific Protocols One of our most significant discoveries has been that the aesthetic needs of a 25-year-old beginning GLP-1 therapy are vastly different from those of a 55-year-old whos been on treatment for months
Clinical trial: the glucagon-like peptide-1 analogue ROSE-010 for management of acute pain in patients with irritable bowel syndrome: a randomized, placebo-controlled, double-blind study
With 25mg of clean caffeine, its built for recovery and made to power you through the afternoon without keeping you up all night
BPC-157 is a stable gastric pentadecapeptide with protective effects on the GI tract, muscle, tendon, and nerve tissue, making it a potential multi-system healing agent. Sikiric et al., Current Pharmaceutical Design What Makes BPC-157 Unique
This vial often encloses lyophilized (freeze-dried) powder that is reconstituted with sterile water for injection before dispensing
Journal of Endocrinological Investigation , 26 (3), 211215